1. Review the new anti-CD20 monoclonal antibodies.
2. Review BTK inhibitors that are currently in trials.
3. Briefly review the use of autologous hematopoietic stem cell transplant.
08/08/2023 - 8:00am to 9:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Carolyn Goldschmidt, DO